Higher immune responses were elicited by mRNA-1083 than high-dose quadrivalent inactivated influenza vaccine for all 4 influenza strains and high-dose quadrivalent inactivated influenza vaccine for 3 ...
FDA has approved Phase II trial for IN002.5.1 SARS-CoV-2 mRNA vaccine. This approval paves the way for the development of combined respiratory virus vaccines. We are thrilled with the FDA's approval ...
As much as we’d like to think that COVID-19 is behind us, the virus isn’t going anywhere. Health officials continue to recommend that people get vaccinated for both COVID-19 and influenza every year ...
The Food and Drug Administration is making it easier for people to simultaneously test themselves for COVID-19 and the flu at home. The agency this week authorized the Healgen Scientific's Rapid Check ...
Schematic of the study design and modelling procedure. Typical Ct value data and model fits for 2 representative individuals with different covariates. The emergence of successive SARS-CoV-2 variants ...
A new study analyzing the immune response to COVID-19 in a Catalan cohort of health workers sheds light on an important ...
mRNA-1083 induced higher immune responses than recommended standard-care influenza and COVID-19 vaccines. (HealthDay News) — mRNA-1083 vaccine is noninferior and induces higher immune responses than ...
The Food and Drug Administration is making it easier for people to simultaneously test themselves for COVID-19 and the flu at home. The agency this week authorized the Healgen Scientific's Rapid Check ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback